We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Automated Characterization of Biotherapeutics via Hardware, Software and Chemistry

In this episode, we welcome Dr Harsha Gunawardena, principal scientist at Jansen Research and Development, Johnson & Johnson. 

Harsha discusses bi & multispecific antibodies including the challenges that manufacturers face when developing novel therapeutics. He reveals how scientists at Janssen are working to deliver better analytical methods and advanced data processing tools to help them streamline biotherapeutic development workflows.

Further Reading:

Brought to you by